Mast cell population in atypical fibroxanthoma as a finding with CD117 immunostaining

American Journal of Dermatopathology

Volumn 30, Issue 6, 2008, Pages 640-642

  Fernandez Flores, Angel ^a,b  

^a HOSPITAL EL BIERZO   (Spain)

^b Service of Cellular Pathology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR;

AGED; CASE REPORT; CELL DENSITY; CELL POPULATION; CELL PROLIFERATION; DERMATOFIBROMA; FEMALE; FIBROXANTHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAST CELL; MERKEL CELL TUMOR; PRIORITY JOURNAL; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; IMMUNOLOGY; MALE; METABOLISM; NOTE; PATHOLOGY; PROGNOSIS; SKIN DISEASE; SKIN TUMOR; XANTHOMATOSIS;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MAST CELLS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; SKIN DISEASES; SKIN NEOPLASMS; XANTHOMATOSIS;

EID: 59849109675     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31817fd3a4     Document Type: Letter

References (26)

1. Mathew RA, Schlauder SM, Calder KB, et al. CD117 immunoreactivity in atypical fibroxanthoma. Am J Dermatopathol. 2008;30:34-36.
2. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/ dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch. 1994;424:135-141.
3. Fukuda T, Kamishima T, Tsuura Y, et al. Expression of the c-kit gene product in normal and neoplastic mast cells but not in neoplastic basophilic/mast cell precursors from chronic myelogenous leukaemia. J Pathol. 1995;177: 139-146.
4. Isaacson P. Mast cells in benign nerve sheath tumours. J Pathol. 1976;119:193-106.
5. Johnson MD, Kamso-Pratt J, Federspiel CF, et al. Mast cell and lymphoreticular infiltrates in neuro-fibromas. Comparison with nerve sheath tumors. Arch Pathol Lab Med. 1989;113:1263-1270.
6. Donhuijsen K, Sastry M, Völker B, et al. Mast cell frequency in soft tissue tumors. Relation to type and grade of malignancy. Pathol Res Pract. 1992;188:61-66.
7. Yamamoto T, Katayama I, Nishioka K. Mast cell numbers in multiple dermatofibromas. Dermatology. 1995;190:9-13.
8. Yamamoto T, Katayama I, Nishioka K. Role of mast cells in dermatofibroma: recent viewpoints into the pathogenesis. Eur J Dermatol. 2003;13: 419-423.
9. Coffin CM, Hornick JL, Zhou H, et al. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with fibromas. Am J Surg Pathol. 2007;31:410-416.
10. Fetsch JF, LaskinWB, Miettinen M. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes. Hum Pathol. 2001; 32:704-714.
11. Misago N, Ohkawa T, Yanai T, et al. Superficial acral fibromyxoma on the tip of the big toe: expression of CD10 and nestin. J Eur Acad Dermatol Venereol. 2008;22:235-262.
12. Gun BD, Bahadir B, Behzatoglu K, et al. Elastofibroma: a clinicopathologic and immunohistochemical study of seven cases and literature review. APMIS. 2007;115:115-119.
13. Smith ME, Fisher C, Weiss SW. Pleomorphic hyalinizing angiectatic tumor of soft parts. A low-grade neoplasm resembling neurilemoma. Am J Surg Pathol. 1996;20:21-29.
14. Silverman JS, Dana MM. Pleomorphic hyalinizing angiectatic tumor of soft parts: immunohistochemical case study shows cellular composition by CD34+ fibroblasts and factor XIIIa+ dendrophages. J Cutan Pathol. 1997; 24:377-383.
15. Capovilla M, Birembaut P, Cucherousset J, et al. Pleomorphic hyalinizing angiectatic tumor of soft parts: ultrastructural analysis of a case with original features. Ultrastruct Pathol. 2006;30:59-64.
16. Ekfors TO, Kulju T, AaltonenM, et al. Ossifying fibromyxoid tumour of soft parts: report of four cases including one mediastinal and one infantile. APMIS. 1998;106:1124-1130.
17. Junkins-Hopkins JM, Johnson WC. Desmoplastic fibroblastoma. J Cutan Pathol. 1998; 25:450-454.
18. Gonzalez-Crussi F, Reyes-Mugica M. Cellular hemangiomas ("hemangioendotheliomas") in infants. Light microscopic, immunohistochemical, and ultrastructural observations. Am J Surg Pathol. 1991;15:769-778.
19. Ide F, Kaoru K. Solitary fibrous tumor is rich in factor XIIIa+ dendrocytes. Am J Dermatopathol. 2002;24:449-450.
20. Puig L, Fernández-Figueras MT, Bielsa I, et al. Multinucleate cell angiohistiocytoma: a fibrohistiocytic proliferation with increased mast cell number and vascular hyperplasia. J Cutan Pathol. 2002;29: 232-237.
21. Brenner S, Martinez de Morentin E. What's new in pseudo-Kaposi's sarcoma. J Eur Acad Dermatol Venereol. 2001;15: 382-384.
22. Ikeda E, Kano E, Baba S, et al. Mast cells in pseudo-Kaposi's sarcoma lesions. J Eur Acad Dermatol Venereol. 2001;15:487-489.
23. Meijer-Jorna LB, van der Loos CM, de Boer OJ, et al. Microvascular proliferation in congenital vascular malformations of skin and soft tissue. J Clin Pathol. 2007;60:798-803.
24. Tan ST, Velickovic M, Ruger BM, et al. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg. 2000;106:529-538.
25. Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of mast cells in soft tissue sarcoma. Cancer. 1988;62:2416-2419.
26. Beer TW, Ng LB, Murray K. Mast cells have prognostic value in Merkel cell carcinoma. Am J Dermatopathol. 2008;30:27-30.